INNODIA screening for early-stage type 1 diabetes: Insights from Polish first-degree relatives of T1D patients (2015–2023, EU115797)
In the Polish cohort of the INNODIA study, autoantibodies were detected in 7.96% of first-degree relatives of individuals with T1D. Early screening is crucial for accurate risk stratification, guiding the development of therapeutic interventions and reducing the risk of severe complications at disease onset.
Authors
- Grażyna Deja
- Magdalena Małachowska (ORCID: https://orcid.org/0009-0008-2147-4316)
- Paulina Pokrywka
- Halla Kamińska (ORCID: https://orcid.org/0000-0003-0960-8365)
- Aleksandra Pyziak-Skupień (ORCID: https://orcid.org/0000-0002-7520-8506)
- Eliza Skała-Zamorowska
- Ewa Rusak
- Sebastian Jacek Seget
- Kamil Kosiorowski
- Przemysława Jarosz-Chobot
Institutions
- Medical University of Silesia (PL)
- Katowice School of Economics (PL)
- University of Silesia in Katowice (PL)
Publication Details
- Journal
- Advances in Clinical and Experimental Medicine
- Published
- 2026-01-13
- DOI
- https://doi.org/10.17219/acem/208837
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Leona M. and Harry B. Helmsley Charitable Trust
- European Federation of Pharmaceutical Industries and Associations
- European Commission